Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

New Biden rule seeks to protect women crossing state lines for abortions

Published 04/12/2023, 09:04 AM
Updated 04/12/2023, 05:06 PM
© Reuters. FILE PHOTO: Abortion rights campaigners and anti-abortion demonstrators hold signs during the annual "March for Life" for the first time since the U.S. Supreme Court overturned Roe v Wade abortion decision, in Washington, U.S. January 20, 2023. REUTERS/Jo

By Jarrett Renshaw and Ahmed Aboulenein

WASHINGTON (Reuters) - The Biden administration on Wednesday proposed new privacy protections to prevent women's health information from being used to investigate or sue people who obtain or facilitate abortions.

The proposal by the U.S. Department of Health and Human Services is aimed at protecting women living in states where abortion is illegal who travel out of state to have the procedure done - something thousands of women are already doing, research shows. The rule would also protect healthcare providers, insurers, or other entities which perform or pay for abortions.

It is unclear whether the proposed rule would actually stifle criminal investigations. Fears of criminal investigations aimed at out-of-state abortions have grown after Idaho this month passed a law explicitly restricting some out-of-state travel for abortions.

Major companies, including JPMorgan Chase & Co (NYSE:JPM), Amazon.com Inc (NASDAQ:AMZN) and Walt Disney (NYSE:DIS) Co, have said they would pay travel costs for employees seeking abortions out of state and provide reimbursement through company-sponsored healthcare plans, but Republican leaders have threatened retribution.

The proposed rule, which is set to be finalized following a 60-day public comment period, strengthens existing privacy protections under the Health Insurance Portability and Accountability Act (HIPAA), which are binding in all states.

It amends the HIPAA Privacy Rule so that existing exceptions that allow the sharing of private health information do not apply to information related to reproductive healthcare - including abortion - for non-healthcare purposes.

The proposed rule specifically prohibits the "use or disclosure" of private health information by regulated entities, which include healthcare providers and health insurance companies among others, for these purposes, including:

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"A criminal, civil, or administrative investigation into or proceeding against any person in connection with seeking, obtaining, providing, or facilitating reproductive health care that is lawful under the circumstances in which it is provided."

It also prohibits "the identification of any person for the purpose of initiating such an investigation or proceeding."

It was not clear, however, how that would work when pitted against state anti-abortion laws which are a matter of criminal, not healthcare, law.

The current HIPAA Privacy Rule says state laws that are contrary to it are preempted by the federal requirements. But it provides exceptions including "the reporting of disease or injury, child abuse, birth, or death, or for public health surveillance, investigation, or intervention."

It also permits - but does not require - the disclosure of protected health information to law enforcement officials under certain circumstances, including complying with court orders, warrants, subpoenas, or for the purposes of identifying or locating suspects and fugitives.

The proposed rule amends some definitions and clarifies others to prohibit the use of these exceptions when it comes to reproductive healthcare.

Vice President Kamala Harris on Friday hosted the third meeting of the Task Force on Reproductive Healthcare Access, an interagency group that has taken on added meaning following a decision by a federal judge in Texas to suspend the U.S. Food and Drug Administration's (FDA) 23-year-old approval of a key abortion drug.

"I do believe that America is facing a healthcare crisis," Harris said at the beginning of the meeting. "I have met with and talked with doctors who are in fear of losing their license or being prosecuted."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A string of judicial decisions and a spate of new state laws have banned women from getting abortions in many circumstances in large parts of the country after last summer's U.S. Supreme Court rollback of Roe vs. Wade.

A senior administration official, speaking on condition of anonymity before the rule was announced, said officials have heard directly from patients and their advocates about privacy concerns.

"They're scared. They are concerned about their medical information being misused and disclosed," the official said, adding that privacy concerns have had a chilling effect on woman seeking medical help.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.